- Home
- KYMR vs AAL Comparison
KYMR vs AAL Comparison
Compare KYMR & AAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | AAL |
|---|---|---|
| Founded | 2015 | 1930 |
| Country | United States | United States |
| Employees | N/A | 133700 |
| Industry | Medicinal Chemicals and Botanical Products | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.7B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | KYMR | AAL |
|---|---|---|
| Price | $113.04 | $15.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 18 |
| Target Price | ★ $107.72 | $15.59 |
| AVG Volume (30 Days) | 1.2M | ★ 145.7M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $39,211,000.00 | ★ $54,633,000,000.00 |
| Revenue This Year | $10.61 | $12.17 |
| Revenue Next Year | $8.17 | $4.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.78 |
| 52 Week Low | $36.88 | $10.09 |
| 52 Week High | $130.05 | $18.79 |
Technical Indicators
Market Signals| Indicator | KYMR | AAL |
|---|---|---|
| Relative Strength Index (RSI) | 58.53 | 42.52 |
| Support Level | $108.87 | $15.02 |
| Resistance Level | $120.90 | $15.39 |
| Average True Range (ATR) | 5.64 | 0.64 |
| MACD | -1.26 | -0.37 |
| Stochastic Oscillator | 37.36 | 7.92 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.